论文部分内容阅读
目的探讨疏血通注射液对2型糖尿病尿微量白蛋白的影响。方法选取2012年8月-2013年8月就诊于医院内科的2型糖尿病患者120例,随机分为对照组和治疗组各60例,对照组给予常规治疗,治疗组在常规治疗基础上加用疏血通注射液,治疗3周后比较2组患者治疗前后空腹血糖及24h尿微量白蛋白的变化。结果与治疗前比较,对照组和治疗组患者治疗后空腹血糖及24h尿微量白蛋白均有明显下降,差异具有统计学意义(P<0.05);治疗后2组患者空腹血糖比较无统计学差异;治疗后治疗组24h尿微量白蛋白改善好于对照组,差异有统计学意义(P<0.05)。2组均无明显不良反应出现。结论疏血通注射液辅助治疗2型糖尿病合并尿微量白蛋白患者,可以有效降低尿微量白蛋白,对防治糖尿病肾病和尿毒症有积极的临床意义。
Objective To investigate the effect of Shuxuetong injection on type 2 diabetes mellitus. Methods A total of 120 patients with type 2 diabetes admitted to the hospital from August 2012 to August 2013 were randomly divided into control group and treatment group, 60 cases in each group. The control group was given routine treatment. The treatment group was given conventional treatment Shuxuetong injection, after 3 weeks of treatment, the fasting blood glucose and 24h urinary albumin in two groups were compared before and after treatment. Results Compared with those before treatment, fasting blood glucose and 24h urinary albumin in control group and treatment group were significantly decreased after treatment (P <0.05), and there was no significant difference in fasting blood glucose between the two groups after treatment After treatment, 24h urinary albumin in treatment group was better than that in control group (P <0.05). No obvious adverse reactions occurred in both groups. Conclusion Shuxuetong injection in the treatment of type 2 diabetes mellitus patients with microalbuminuria, can effectively reduce the urine microalbumin, the prevention and treatment of diabetic nephropathy and uremia has a positive clinical significance.